Sample Request

COVID-19 Outbreak-Global Pharmacovigilance and Drug Safety Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

SELECT LICENSE:

Published on 01/19/2021| Code: MAR41115D| Category: Utilities| Total Pages: 107

The Pharmacovigilance and Drug Safety market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Pharmacovigilance and Drug Safety industry.

Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Pharmacovigilance and Drug Safety market can be split based on product types, major applications, and important countries as follows:

Key players in the global Pharmacovigilance and Drug Safety market covered in Chapter 12:

Arriello
CROMSOURCE
TPIreg
Medpace
Bioclinica
Sciformix (Covance)
FMD K&L

In Chapter 4 and 14.1, on the basis of types, the Pharmacovigilance and Drug Safety market from 2015 to 2025 is primarily split into:

Pharmacovigilance
Drug Safety

In Chapter 5 and 14.2, on the basis of applications, the Pharmacovigilance and Drug Safety market from 2015 to 2025 covers:

Pharma and Biotech Companies
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:

North America (Covered in Chapter 7 and 14)

United States

Canada

Mexico

Europe (Covered in Chapter 8 and 14)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 9 and 14)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 10 and 14)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 11 and 14)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Table of Content

1 Pharmacovigilance and Drug Safety Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of Pharmacovigilance and Drug Safety

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the Pharmacovigilance and Drug Safety industry

1.4 Methodology of The Study

1.5 Research Data Source

2 Executive Summary

2.1 Market Overview

2.1.1 Global Pharmacovigilance and Drug Safety Market Size, 2015 – 2020

2.1.2 Global Pharmacovigilance and Drug Safety Market Size by Type, 2015 – 2020

2.1.3 Global Pharmacovigilance and Drug Safety Market Size by Application, 2015 – 2020

2.1.4 Global Pharmacovigilance and Drug Safety Market Size by Region, 2015 - 2025

2.2 Business Environment Analysis

2.2.1 Global COVID-19 Status and Economic Overview

2.2.2 Influence of COVID-19 Outbreak on Pharmacovigilance and Drug Safety Industry Development

3 Industry Chain Analysis

3.1 Upstream Raw Material Suppliers of Pharmacovigilance and Drug Safety Analysis

3.2 Major Players of Pharmacovigilance and Drug Safety

3.3 Pharmacovigilance and Drug Safety Manufacturing Cost Structure Analysis

3.3.1 Production Process Analysis

3.3.2 Manufacturing Cost Structure of Pharmacovigilance and Drug Safety

3.3.3 Labor Cost of Pharmacovigilance and Drug Safety

3.4 Market Distributors of Pharmacovigilance and Drug Safety

3.5 Major Downstream Buyers of Pharmacovigilance and Drug Safety Analysis

3.6 The Impact of Covid-19 From the Perspective of Industry Chain

3.7 Regional Import and Export Controls Will Exist for a Long Time

3.8 Continued downward PMI Spreads Globally

4 Global Pharmacovigilance and Drug Safety Market, by Type

4.1 Global Pharmacovigilance and Drug Safety Value and Market Share by Type (2015-2020)

4.2 Global Pharmacovigilance and Drug Safety Production and Market Share by Type (2015-2020)

4.3 Global Pharmacovigilance and Drug Safety Value and Growth Rate by Type (2015-2020)

4.3.1 Global Pharmacovigilance and Drug Safety Value and Growth Rate of Pharmacovigilance
4.3.2 Global Pharmacovigilance and Drug Safety Value and Growth Rate of Drug Safety
4.4 Global Pharmacovigilance and Drug Safety Price Analysis by Type (2015-2020)

5 Pharmacovigilance and Drug Safety Market, by Application

5.1 Downstream Market Overview

5.2 Global Pharmacovigilance and Drug Safety Consumption and Market Share by Application (2015-2020)

5.3 Global Pharmacovigilance and Drug Safety Consumption and Growth Rate by Application (2015-2020)

5.3.1 Global Pharmacovigilance and Drug Safety Consumption and Growth Rate of Pharma and Biotech Companies (2015-2020)
5.3.2 Global Pharmacovigilance and Drug Safety Consumption and Growth Rate of Contract Research Organizations (CROs) (2015-2020)
5.3.3 Global Pharmacovigilance and Drug Safety Consumption and Growth Rate of Business Process Outsourcing (BPO) Firms (2015-2020)

6 Global Pharmacovigilance and Drug Safety Market Analysis by Regions

6.1 Global Pharmacovigilance and Drug Safety Sales, Revenue and Market Share by Regions

6.1.1 Global Pharmacovigilance and Drug Safety Sales by Regions (2015-2020)

6.1.2 Global Pharmacovigilance and Drug Safety Revenue by Regions (2015-2020)

6.2 North America Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

6.3 Europe Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

6.4 Asia-Pacific Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

6.5 Middle East and Africa Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

6.6 South America Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

7 North America Pharmacovigilance and Drug Safety Market Analysis by Countries

7.1 The Influence of COVID-19 on North America Market

7.2 North America Pharmacovigilance and Drug Safety Sales, Revenue and Market Share by Countries

7.2.1 North America Pharmacovigilance and Drug Safety Sales by Countries (2015-2020)

7.2.2 North America Pharmacovigilance and Drug Safety Revenue by Countries (2015-2020)

7.3 United States Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

7.4 Canada Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

7.5 Mexico Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

8 Europe Pharmacovigilance and Drug Safety Market Analysis by Countries

8.1 The Influence of COVID-19 on Europe Market

8.2 Europe Pharmacovigilance and Drug Safety Sales, Revenue and Market Share by Countries

8.2.1 Europe Pharmacovigilance and Drug Safety Sales by Countries (2015-2020)

8.2.2 Europe Pharmacovigilance and Drug Safety Revenue by Countries (2015-2020)

8.3 Germany Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

8.4 UK Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

8.5 France Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

8.6 Italy Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

8.7 Spain Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

8.8 Russia Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

9 Asia Pacific Pharmacovigilance and Drug Safety Market Analysis by Countries

9.1 The Influence of COVID-19 on Asia Pacific Market

9.2 Asia Pacific Pharmacovigilance and Drug Safety Sales, Revenue and Market Share by Countries

9.2.1 Asia Pacific Pharmacovigilance and Drug Safety Sales by Countries (2015-2020)

9.2.2 Asia Pacific Pharmacovigilance and Drug Safety Revenue by Countries (2015-2020)

9.3 China Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

9.4 Japan Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

9.5 South Korea Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

9.6 India Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

9.7 Southeast Asia Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

9.8 Australia Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

10 Middle East and Africa Pharmacovigilance and Drug Safety Market Analysis by Countries

10.1 The Influence of COVID-19 on Middle East and Africa Market

10.2 Middle East and Africa Pharmacovigilance and Drug Safety Sales, Revenue and Market Share by Countries

10.2.1 Middle East and Africa Pharmacovigilance and Drug Safety Sales by Countries (2015-2020)

10.2.2 Middle East and Africa Pharmacovigilance and Drug Safety Revenue by Countries (2015-2020)

10.3 Saudi Arabia Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

10.4 UAE Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

10.5 Egypt Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

10.6 Nigeria Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

10.7 South Africa Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

11 South America Pharmacovigilance and Drug Safety Market Analysis by Countries

11.1 The Influence of COVID-19 on Middle East and Africa Market

11.2 South America Pharmacovigilance and Drug Safety Sales, Revenue and Market Share by Countries

11.2.1 South America Pharmacovigilance and Drug Safety Sales by Countries (2015-2020)

11.2.2 South America Pharmacovigilance and Drug Safety Revenue by Countries (2015-2020)

11.3 Brazil Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

11.4 Argentina Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

11.5 Columbia Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

11.6 Chile Pharmacovigilance and Drug Safety Sales and Growth Rate (2015-2020)

12 Competitive Landscape

12.1 Arriello
12.1.1 Arriello Basic Information
12.1.2 Pharmacovigilance and Drug Safety Product Introduction
12.1.3 Arriello Production, Value, Price, Gross Margin 2015-2020
12.2 CROMSOURCE
12.2.1 CROMSOURCE Basic Information
12.2.2 Pharmacovigilance and Drug Safety Product Introduction
12.2.3 CROMSOURCE Production, Value, Price, Gross Margin 2015-2020
12.3 TPIreg
12.3.1 TPIreg Basic Information
12.3.2 Pharmacovigilance and Drug Safety Product Introduction
12.3.3 TPIreg Production, Value, Price, Gross Margin 2015-2020
12.4 Medpace
12.4.1 Medpace Basic Information
12.4.2 Pharmacovigilance and Drug Safety Product Introduction
12.4.3 Medpace Production, Value, Price, Gross Margin 2015-2020
12.5 Bioclinica
12.5.1 Bioclinica Basic Information
12.5.2 Pharmacovigilance and Drug Safety Product Introduction
12.5.3 Bioclinica Production, Value, Price, Gross Margin 2015-2020
12.6 Sciformix (Covance)
12.6.1 Sciformix (Covance) Basic Information
12.6.2 Pharmacovigilance and Drug Safety Product Introduction
12.6.3 Sciformix (Covance) Production, Value, Price, Gross Margin 2015-2020
12.7 FMD K&L
12.7.1 FMD K&L Basic Information
12.7.2 Pharmacovigilance and Drug Safety Product Introduction
12.7.3 FMD K&L Production, Value, Price, Gross Margin 2015-2020

13 Industry Outlook

13.1 Market Driver Analysis

13.1.2 Market Restraints Analysis

13.1.3 Market Trends Analysis

13.2 Merger, Acquisition and New Investment

13.3 News of Product Release

14 Global Pharmacovigilance and Drug Safety Market Forecast

14.1 Global Pharmacovigilance and Drug Safety Market Value & Volume Forecast, by Type (2020-2025)

14.1.1 Pharmacovigilance Market Value and Volume Forecast (2020-2025)
14.1.2 Drug Safety Market Value and Volume Forecast (2020-2025)
14.2 Global Pharmacovigilance and Drug Safety Market Value & Volume Forecast, by Application (2020-2025)

14.2.1 Pharma and Biotech Companies Market Value and Volume Forecast (2020-2025)
14.2.2 Contract Research Organizations (CROs) Market Value and Volume Forecast (2020-2025)
14.2.3 Business Process Outsourcing (BPO) Firms Market Value and Volume Forecast (2020-2025)
14.3 Pharmacovigilance and Drug Safety Market Analysis and Forecast by Region

14.3.1 North America Market Value and Consumption Forecast (2020-2025)

14.3.2 Europe Market Value and Consumption Forecast (2020-2025)

14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)

14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)

14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 New Project Feasibility Analysis

15.1 Industry Barriers and New Entrants SWOT Analysis

15.1.1 Porter’s Five Forces Analysis

15.1.2 New Entrants SWOT Analysis

15.2 Analysis and Suggestions on New Project Investment

Our Clients

BIC
Suntory Holdings
Continental AG
Ernst Klett
felix
IF Logo
ITC logo
jc
KB
KKR
LR
LSC
Mizuno corporation
Prospect
SRG
Sumitomo
Taichin logo
The Cleanest Way
Meat & Livestock Australia Limited
LEK
IFFCO
STTS
Laundry Capital LLC
Chippenhook Corporation
SAB
IJIN
Hooton
Medica
Medalliacne
Shanghai Chenzhu Instrument Co., Ltd.
Sanofi
Kleen Linnebo und Partner GbR
Bond-Pro, Inc.
E&L Faster Food Imports Inc.
Okinawa Institute of Science and Technology

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005